TMCnet News
Myomo, Inc. Introduces Center of Excellence ProgramMyomo®, Inc. (NYSE MKT: MYO) ("Myomo" or the "Company"), a commercial stage medical robotics company, today announced the launch of its Center of Excellence (CoE) program, which recognizes top orthotics and prosthetics ("O&P") practices in the U.S. that support its MyoPro® line of powered orthoses. MyoPro is the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury, or other neuromuscular disability. With the orthosis, a paralyzed individual can perform activities of daily living including feeding themselves, carrying objects and doing household tasks, and many are able to return to work. As a Myomo CoE, an O&P practice participates in joint marketing and receives training and patient support from Myomo and its network of clinical partners. Seven O&P practice organizations with a combined 31 locations across the U.S. have now met the training, quality and patient support qualifications to be recognized as a Myomo CoE. These are:
"MyoPro is one of the most exciting and unique products to come along to the O&P industry in the last decade," said Thomas Kirk, member of the Myomo board of directors, former president of the American Orthotics and Prosthetics Association (AOPA), and former CEO of Hanger, Inc., the largest provider of O&P services in the U.S. "For those patients in the middle, where they had impaired functionality but still had the limb in place, there was no alternative and no answer. MyoPro, however, enables O&P practices to offer a highly functional upper extremity product that fills the gap between a passive orthosis and a prosthetic for amputees. As CoEs, O&P practitioners can treat a broader range of patients." "We look forward to working with these organizations who have demonstrated the product knowledge, skills supporting patients and revenue potential to qualify as Myomo Centers of Excellence," said Paul R. Gudonis, Chairman and CEO of Myomo. "We are already planning joint continuing education courses for clinicians, joint media outreach and other joint activities with several of them, while also recruiting additional O&P firms across the U.S. to become Centers of Excellence." Myomo CoEs partner with physicians and therapists at leading U.S. rehabilitation hospitals, who recommend and prescribe MyoPro as well as train new MyoPro users. These rehabilitation hospitals include Presbyterian Hospital, Hospital for Special Surgery, Helen Hayes Rehabilitation Hospital and Burke Rehabilitation Hospital in New York; Mayo Clinic in Minnesota; The Kennedy Krieger Institute/Johns Hopkins Hospital in Baltimore; MedStar National Rehabilitation Hospital in Washington, D.C.; Cleveland Clinic, University Hospitals, Lake Health and MetroHealth in the Cleveland area; HealthSouth Braintree Rehabilitation Hospital, Spaulding Rehabilitation Hospital and Massachusetts General Hospital in the Boston area; Loma Linda University Medical Center, Stanford University Medical Center and Centre for Neuro Skills in California; University of Kansas Medical Center; Washington University Medical Center in St. Louis; Rehabilitation Institute of Chicago; Northwestern Memorial Hospital in Chicago; University of Wisconsin Hospital; and University of Miami Hospital. In addition, Myomo distribution partner Ottobock, based in Germany and a world market leader in technical orthopedics, is marketing the MyoPro product line to Veterans Administration (VA) medical centers across the U.S. VA medical centers receive the same type of clinical training and support as commercial O&P practices in the CoE program.
About Myomo
Forward Looking Statements
View source version on businesswire.com: http://www.businesswire.com/news/home/20170712005624/en/ |